Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Laurence Malcolm a Aotearoa
Health, Lyttelton RD1, New Zealand, b Social Policy Branch, Treasury,
Wellington, New Zealand
Correspondence to: L Malcolm laurelyn{at}chch.planet.org.nz
Clinical governance has achieved "band wagon" status in
recent months in the United Kingdom.1-3 Yet there remains
considerable confusion and uncertainty about its scope and purpose.
Since 1991-2, the NHS has invested in the development of clinical
audit, but this has rarely been related to the parallel development of
various forms of devolved budget holding, both within hospitals and in primary care. However, we believe the integration of clinical and
financial accountability is essential for the development of effective
clinical governance. Over the past five years, New Zealand's
independent practitioner associations have been developing a working
model of such clinical governance in primary care.
4 5
We
think this is relevant to clinical governance in budget holding primary
care groups in England and local health groups in Wales. Although
Scotland's local health care cooperatives do not hold budgets or
commission services, they too will need to make arrangements for
clinical governance.
From April 1999, the chief executive of each NHS trust
(including new primary care trusts) became responsible not only for the
financial health of the organisation but also for the quality of its
clinical services. The key elements identified by the NHS to enable
this to happen are clinical audit, clinical risk management, quality
assurance, clinical effectiveness, and staff and organisational development.6 The consultation document A First
Class Service defined clinical governance as "a framework
through which NHS organisations are accountable for continuously
improving the quality of their services and safeguarding high standards
of care by creating an environment in which excellence in clinical care
will flourish."3 This definition does not refer to the
collective management of resources. This may be intentional, given the
reluctance of clinicians to accept a role in priority setting. But it
is plain that managers (and clinicians) cannot ignore the financial
dimension of their new twin responsibilities.
Thus the emerging NHS view of governance seems to be much more
restricted than the general use of the term. Donaldson, a key NHS
promoter of the concept, stated, early in the debate, that "the term
clinical governance resonates with that of corporate governance, a set
of financial duties, accountablities, and rules of
conduct."1 Yet a recent paper on clinical governance did not mention management of resources.7
Should clinical governance by primary care groups be implemented simply
as an extension and formalisation of current initiatives to monitor and
audit performance, promote quality, and maximise clinical effectiveness
through guidelines and evidence based practice? Or is it mechanism
through which teams of clinicians improve the quality of care while
sharing the management of scarce resources? And what is the role of
clinical governance at the corporate level? New Zealand's experience
of independent practitioner associations may help answer these questions.
New Zealand's associations began in 1992-3 as a response by
general practitioners to the perceived threats posed by health reforms.4-11 They are similar in many respects to primary
care groups but are owned and controlled independently by the general practitioners themselves.
4 5
Unlike British general
practitioners, 80% of New Zealand's general practitioners are still
paid for general medical services by "fee for service." Typically,
they derive only about a third of their income from the public purse, mainly for subsidised visits by children and people on low incomes. However, there is increasing interest, particularly among association leaders, in payment by capitation for general medical services.
There are now over 30 associations, ranging from 7 to 340 members
(mean 74) and representing over 75% of general
practitioners.5 Associations are governed by boards of
management elected by members. Some have extended board membership to
community representatives and a quarter include members other than
general practitioners.
4 5
The purchasing authority is not
represented and remains at arm's length in a contractual relationship.
Majeed and Malcolm discussed the contrasts between England's primary
care groups and New Zealand's associations,8 and the
table shows the features relevant to clinical
governance.
Summary points
The scope and application of clinical governance in the United
Kingdom remain unclear
New Zealand's independent practitioner associations are implementing a
working model of clinical governance in primary care
This is achieved through an elected board, accountable to the
purchasing authority for large and increasing amounts of public funding
Associations have a well established infrastructure, including staff,
information systems, clinical guidelines, peer discussion groups, and
personalised feedback on clinical performance
Associations have used budget holding to make savings to develop new
and better services
![]()
Clinical governance in the NHS
Top
Clinical governance in the...
New Zealand's independent...
Is this clinical governance?
UK experience
What can be learnt...
References
![]()
New Zealand's independent practitioner associations
Top
Clinical governance in the...
New Zealand's independent...
Is this clinical governance?
UK experience
What can be learnt...
References
Almost all associations have now taken on responsibility for non-general medical services budgets for laboratory and pharmaceutical services, in addition to developing new services. 4 5 11-14 The main incentive has been the opportunity to improve the quality of clinical decision making and achieve savings to develop new services. The main sources of finance are from budget holding savings and government grants. 4 5 For the purchaser, the incentive was to minimise the risks of growing, largely uncontrolled, expenditure on laboratory and pharmaceutical services. Budgets have so far been historical, and associations have been able keep a varying proportion of their savings. 4 5 8-11
Associations have established comprehensive information systems, computerised practice registers (now in nearly all member practices), personalised feedback on prescribing behaviour and laboratory use, and peer group discussion of guidelines. 4 5 12-14 This has identified wide variations in clinical behaviour. To build a more comprehensive primary health care service, corporate initiatives include building relationships with other primary care professionals such as nurses and midwives. Many new forms of community participation are being established. These represent the equivalent of accountability to shareholders in a firm. New service integration projects are also being developed between primary and secondary care in a system which has been notoriously fragmented in the past.4-6
The national purchaser recently signed a contract with the associations
to move to population based equitable funding, especially of laboratory
and pharmaceutical services for all general practitioners, but the
timing and strategies to achieve this remain unclear. The immediate
consequence for associations will be the need to address inappropriate
variation in expenditure between and within associations. A related
issue is how to address poor quality practice and the nature of any
sanctions needed to achieve this.5
| |
Is this clinical governance? |
|---|
|
|
|---|
We believe that associations have succeeded in putting in place the prerequisites for clinical governance. They have established an infrastructure, appointed key staff, developed information systems, prepared clinical guidelines, and introduced personalised feedback and peer discussion groups. 4 5 12-14 Better quality prescribing is being facilitated by trained staff who visit selected practices. 12 13 Major efforts have been made to develop both internal as well as external relationships.6
Most importantly, general practitioners have developed collective
professional responsibility for expenditure, especially for laboratory
and pharmaceutical services. Evaluations have shown savings from 5% to
23% in laboratory services in just over a
year.
4 5 12-14
This gives associations the opportunity
to shift resources between services according to their priorities
for
example, using savings to improve immunisation levels15
and disease management programmes.
4 5
Yet, most associations continue to reject bearing full financial
risk.
4 5
This is understandable. Like the boards of public hospitals, they manage large sums of public money. Unlike such
boards, they have no capital base against which to borrow to cover
overexpenditure. They face political and professional risks, which make
them cautious about taking on the full financial risk. Furthermore,
they assert that their goals and incentives are primarily professional,
not commercial. Consequently, nearly all associations reject direct
personal gain, seeing it as both unprofessional and
unethical.
4 5
Although the associations consist of
private providers, they see themselves as "quasi-public" bodies,
managing additional public money to achieve public goals. Only
indirectly does this assist in improving the financial circumstances of
members. This is similar to the position of the former general practitioner fundholders in Britain, who could not profit directly from
their actions.
| |
UK experience |
|---|
|
|
|---|
The experience in Britain suggests, similarly, that delegating budgets to general practices can generate incentives for practitioners to review their use of resources, even when practices do not bear the full financial risk. Under fundholding, the prescribing budget presented a stronger, direct incentive to manage pharmaceutical costs than the indicative budget given to non-fundholders, despite the fact that the only sanction for overspending fundholders was removal from the scheme. Fundholders were able to contain the rate of increase in their drug costs more effectively than non-fundholders. This was achieved by reducing the cost of each item rather than prescribing fewer items. 16 17
Likewise, in the pilot extension to fundholding known as total
purchasing, projects which were granted greater budgetary
responsibility by the parent health authority seemed to achieve more
than those with indicative budgets.18 Also, larger,
multipractice pilot projects found it more difficult than single
practice pilots to adjust their patterns and levels of spending to
remain within budget.19 They were far more likely than
single practices to leave responsibility for reviewing expenditure
against budget and for taking action to the lead general practitioner
rather than making all general practitioners responsible. The reaction to financial pressures was to delay non-urgent treatment rather than
attempt to influence the referral rates of individual practitioners, suggesting that clinical governance was still relatively immature.
| |
What can be learnt from New Zealand? |
|---|
|
|
|---|
The experience of the total purchasing pilots highlights the importance of effective commissioning of services and collective management of resources and clinical activity. This requires development of a strong management infrastructure capable of linking independent practices and practitioners. Independent practitioner associations in New Zealand have gone further than fundholding groups, total purchasing pilots, or the new primary care groups along this road. This has been particularly noticeable in the collection, analysis, and use of comparative information on individual practitioner performance across the associations. The information has been used to shape practice in order to make better use of resources.
By contrast, some participants in primary care groups seem to be unwilling to accept that finite budgets might require changes in practitioner behaviour. 20 21 This reluctance has been reinforced by ministers' unwillingness publicly to restrict the freedom of general practitioners to prescribe and refer as they see fit.22 At this stage, there is still much uncertainty about what this will mean in practice and, particularly, how budgets might be set. 21 23 On the other hand, the current commissioning pilots in England, which manage a collective, cash limited pharmaceutical budget, like the primary care groups, have shown that volunteer practices are willing and able to use a range of techniques to shape the quality and cost of individual practitioners' prescribing. These include formularies, prescribing groups, sharing prescribing data, and incentive schemes.24 The box gives the main lessons that can be learnt from New Zealand by primary care groups and local health groups.
|
What can be learnt from New Zealand's independent
practitioner associations
|
| |
Acknowledgments |
|---|
We thank Chris Ham for his helpful comments. The views are those of the authors and do not necessarily reflect the views of the New Zealand Treasury, in the case of NM. The Treasury takes no responsibility for any errors in, or for the correctness of, the information in this article.
| |
Footnotes |
|---|
Funding: None.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Donaldson LJ. Clinical governance: a statutory duty for quality improvement [editorial]. J Epidemiology Community Health 1998; 52: 73-74[Medline]. |
| 2. |
Scally G, Donaldson L.
Clinical governance and the drive for quality improvement in the new NHS in England.
BMJ
1998;
317:
61-65 |
| 3. | Secretary of State for Health. A first class service. London: Department of Health, 1998. |
| 4. | Malcolm L, Wright L, Barnett P. Emerging clinical governance: developments in independent practitioner associations in New Zealand. N Z Med J (in press). |
| 5. | Malcolm L, Wright L, Barnett P. The development of primary care organisations in New Zealand: a review undertaken for Treasury and the Ministry of Health. Lyttelton: Aotearoa Health (in press.) |
| 6. | NHS Executive. Clinical governance in North Thames: a paper for discussion and consultation. London: NHSE North Thames Regional Office, 1998. |
| 7. |
Baker R, Lakhani M, Fraser R, Cheater F.
A model for clinical governance in primary care groups.
BMJ
1999;
318:
779-783 |
| 8. |
Majeed A, Malcolm L.
Unified budgets for primary care groups.
BMJ
1999;
318:
772-776 |
| 9. | Malcolm L, Powell M. The development of independent practice associations in New Zealand. N Z Med J 1996; 109: 184-187[Medline]. |
| 10. | Jansen P. Independent practitioner associations: improving the quality of health care. N Z Med J 1997; 110: 85-86[Medline]. |
| 11. |
Malcolm L.
GP budget holding in New Zealand: lessons for Britain and elsewhere?
BMJ
1997;
314:
1890-1892 |
| 12. | Malcolm L, Wright L, Seers M, Guthrie J. An evaluation of pharmaceutical management and budget holding in Pegasus Medical Group. N Z Med J 1999; 112: 162-164[Medline]. |
| 13. | Malcolm L. Evaluation of pharmaceutical budget holding in ProCare Health Limited. Auckland: ProCare Health, 1997. |
| 14. | Kerr D, Malcolm L, Schousboe J, Pimm F. Successful implementation of laboratory budget holding by Pegasus Medical Group. N Z Med J 1996; 109: 354-357. |
| 15. | Bell DW, Ford RPK, Slade B, McCormack SP. Immunisation coverage in Christchurch in a birth cohort. N Z Med J 1997; 110: 440-442[Medline]. |
| 16. |
Harris C, Scrivener G.
Fundholders' prescribing costs: the first five years.
BMJ
1996;
313:
1531-1534 |
| 17. |
Rafferty T, Wilson-Davis K, McGavock H.
How has fundholding in Northern Ireland affected prescribing patterns? A longitudinal study.
BMJ
1997;
315:
166-170 |
| 18. | Mays N, Goodwin N, Killoran A, Malbon G. Total purchasing: a step towards primary care groups. London: King's Fund, 1998. |
| 19. | Bevan G, Baxter K, Bachmann M. Survey of budgetary and risk management of total purchasing pilot projects, 1996/97. London: King's Fund, 1998(National evaluation of total purchasing pilot projects working paper.) |
| 20. | Street A, Place M. The management challenges for primary care groups. London: King's Fund, 1998(National evaluation of total purchasing pilot projects working paper.) |
| 21. | Malbon G, Gillam S, Mays N. Clinical governance: onus points. Health Service Journal 1998; 108: 28-29[Medline]. |
| 22. | Milburn A. The new NHS. Letter to Dr John Chisholm, Chairman, General Medical Services Committee, British Medical Association. London: Department of Health, 17 June 1998. |
| 23. |
Smith P.
Setting budgets for general practice in the new NHS.
BMJ
1999;
318:
776-779 |
| 24. | Regen E, Smith J, Shapiro J. First off the starting blocks: lessons from GP commissioning pilots for PCGs. Initial report. Birmingham: Health Services Management Centre, University of Birmingham, 1999. |
(Accepted 16 August 1999)
Read all Rapid Responses